Welcome to LookChem.com Sign In|Join Free

CAS

  • or

16017-76-8

2-Chloro-6-hydroxy-7-methylpurine is a chemical compound with the molecular formula C6H5ClN4O. It is composed of six carbon atoms, five hydrogen atoms, one chlorine atom, four nitrogen atoms, and one oxygen atom. 2-CHLORO-6-HYDROXY-7-METHYLPURINE features the purine base, which is a core component in nucleic acids, making it a derivative of purine. Although its specific scientific and safety information is not widely available, it has been identified for potential use in biochemical research applications. Due to the limited information, it is crucial to handle this chemical with caution and adhere to proper safety protocols.

16017-76-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 16017-76-8 Structure

  • Basic information

    1. Product Name: 2-CHLORO-6-HYDROXY-7-METHYLPURINE
    2. Synonyms: 2-CHLORO-6-HYDROXY-7-METHYLPURINE;2-Chloro-7-Methyl-7H-purin-6-ol
    3. CAS NO:16017-76-8
    4. Molecular Formula: C6H5ClN4O
    5. Molecular Weight: 184.58
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 16017-76-8.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 456.2 °C at 760 mmHg
    3. Flash Point: 229.7 °C
    4. Appearance: /
    5. Density: 1.79 g/cm3
    6. Vapor Pressure: 1.65E-08mmHg at 25°C
    7. Refractive Index: 1.789
    8. Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
    9. Solubility: N/A
    10. CAS DataBase Reference: 2-CHLORO-6-HYDROXY-7-METHYLPURINE(CAS DataBase Reference)
    11. NIST Chemistry Reference: 2-CHLORO-6-HYDROXY-7-METHYLPURINE(16017-76-8)
    12. EPA Substance Registry System: 2-CHLORO-6-HYDROXY-7-METHYLPURINE(16017-76-8)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 16017-76-8(Hazardous Substances Data)

16017-76-8 Usage

Uses

Used in Biochemical Research Applications:
2-Chloro-6-hydroxy-7-methylpurine is utilized as a research compound for its potential role in biochemical studies. Its structure, which includes the purine base, may offer insights into the understanding of nucleic acids and related biological processes. However, due to the limited availability of specific scientific information, its application in this field is likely to be quite specialized and requires careful handling within the appropriate safety measures.

Check Digit Verification of cas no

The CAS Registry Mumber 16017-76-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,0,1 and 7 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 16017-76:
(7*1)+(6*6)+(5*0)+(4*1)+(3*7)+(2*7)+(1*6)=88
88 % 10 = 8
So 16017-76-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H5ClN4O/c1-11-2-8-4-3(11)5(12)10-6(7)9-4/h2H,1H3,(H,9,10,12)

16017-76-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Chloro-7-methyl-7H-purin-6-ol

1.2 Other means of identification

Product number -
Other names 2-chloro-7-methyl-3H-purin-6-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16017-76-8 SDS

16017-76-8Relevant articles and documents

OXADIAZOLE TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS

-

, (2019/09/30)

The invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof wherein A, X, R1, R4 and n are as defined herein. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 16017-76-8